Lataa...

Development and evaluation of a novel microemulsion formulation of elacridar to improve its bioavailability

The study objective was to develop a formulation of elacridar to overcome its dissolution-rate limited bioavailability. Elacridar is a P-gp and BCRP inhibitor that has been used to improve the brain distribution of drugs that are substrates of P-gp and BCRP. The chronic use of elacridar is restricte...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Sane, Ramola, Mittapalli, Rajendar K., Elmquist, William F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3967790/
https://ncbi.nlm.nih.gov/pubmed/23334925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.23450
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!